These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1209 related items for PubMed ID: 16315641

  • 1. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T.
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [Abstract] [Full Text] [Related]

  • 5. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 6. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P.
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [Abstract] [Full Text] [Related]

  • 7. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 9. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 11. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M.
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [Abstract] [Full Text] [Related]

  • 12. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 13. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
    Arvieux J, Darnige L, Hachulla E, Roussel B, Bensa JC, Colomb MG.
    Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
    [Abstract] [Full Text] [Related]

  • 14. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 15. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B, Eckmann CM, van Schagen M, Meijer AB, Mertens K, van Mourik JA.
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [Abstract] [Full Text] [Related]

  • 16. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O.
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [Abstract] [Full Text] [Related]

  • 17. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y.
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [Abstract] [Full Text] [Related]

  • 18. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
    Gardiner C, Cohen H, Jenkins A, Machin SJ, Mackie IJ.
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
    [Abstract] [Full Text] [Related]

  • 19. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 20. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM.
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 61.